Treatment with Acarbose, an -Glucosidase Inhibitor, Reduces Increased Albumin Excretion in Streptozotocin-Diabetic Rats

Author： Cohen M.P. Vasselli J.R. Neuman R.G. Witt J.

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.26, Iss.6, 1995-10, pp. : 1355-1361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Chronic Treatment with Amlodipine in Streptozotocin-Diabetic and Spontaneously Hypertensive Rats

By Srinivasan P.S. Hakim Z.S. Santani D.D. Goyal R.K.

Pharmacological Research, Vol. 35, Iss. 5, 1997-05 ,pp. : 423-428

Academic Press

Access to resources Recommend Favorite

Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats

By Zheng Dezhi Zhong Guocheng Hu Yonghe

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 9, 2013-01 ,pp. : 759-763

NRC Research Press

Access to resources Recommend Favorite

Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids

By Dryden S. Burns S.J. Frankish H.M. Williams G.

European Journal of Pharmacology, Vol. 340, Iss. 2, 1997-12 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite

The effect of agmatine on the vascular reactivity in streptozotocin-diabetic rats

By Ozyazgan S. Bicakci B. Ozaydin A. Denizbasi A. Unluer E.E. Akkan A.G.

Pharmacological Research, Vol. 48, Iss. 2, 2003-08 ,pp. : 133-138

Elsevier

Access to resources Recommend Favorite

The effects of chronic L-arginine treatment on vascular responsiveness of streptozotocin-diabetic rats - anything beyond a substrate for the NO-synthase?

By Ozcelikay A.T. Tay A. Dincer D. Meral S. Yildizoglu-Ari N. Altan V.M.

General Pharmacology, Vol. 33, Iss. 4, 1999-10 ,pp. : 299-306

Elsevier

Access to resources Recommend Favorite